Setting and participants
anxiety disorder, diabetes mellitus schizophrenia, fibromyalgia, depressive disorder, psychiatric, hypertension
IRRITABLE BOWEL SYNDROME, FIBROMYALGIA, CHRONIC FATIGUE SYNDROME, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, HYPERTENSION
Fifteen multidisciplinary health care centers, with in total 110.000 patients, participated. Patients were eligible if they were 18 years or older, had at least five GP’s consultations in the past 12 months, of which three or more resulted in a diagnosis suggestive of MUPS. Furthermore, patients with an established chronic MUPS diagnosis (i.e. fibromyalgia, chronic fatigue syndrome or irritable bowel syndrome) and a confirmed medical and/or psychiatric diagnosis (i.e. chronic obstructive pulmonary disease, hypertension or diabetes mellitus schizophrenia, anxiety disorder or depressive disorder) were excluded.Eligible patients were approached using three strategies [